|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Thoracic Surgery, University of Freiburg, Hugstetter Str. 55, Freiburg, 79106 Germany
(Email: bernward.passlick{at}uniklinik-freiburg.de).
With interest we noticed the report by Okumura and colleagues [1] on circulating tumor cells in the pulmonary vein of patients with primary lung cancer. Okumura and colleagues [1] analyzed the peripheral blood and blood from the pulmonary vein in 30 consecutive lung cancer patients by using the so-called "cell search system" to detect circulating tumor cells. However, it should be realized that in 2003 our group already published a study [2] on more than 60 patients analyzing the blood of the tumor-draining vein of patients with resectable non-small cell lung cancer. By using an immunohistochemical analysis with a monoclonal antibody A45-B/B3, we were able to detect tumor cells in approximately 18% of our patients. Although this phenomenon did not correlate with standard clinical pathologic measurements, it was an independent prognostic factor at least in patients without mediastinal lymph node involvement. The number of tumor cells in the pulmonary veins, as detected by Okumura and colleagues [1], seems to be astonishingly high (ie, 96.7% of the patients). Therefore, it seems to be questionable as to whether the system used by the colleagues is really specific for the detection of tumor cells in the pulmonary vein.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
F. Tanaka, Y. Okumura, K. Yoneda, and S. Hasegawa Reply. Ann. Thorac. Surg., December 1, 2009; 88(6): 2071 - 2071. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |